0001530766-15-000004.txt : 20150403 0001530766-15-000004.hdr.sgml : 20150403 20150403155152 ACCESSION NUMBER: 0001530766-15-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150403 DATE AS OF CHANGE: 20150403 EFFECTIVENESS DATE: 20150403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-231214 FILM NUMBER: 15751263 BUSINESS ADDRESS: STREET 1: 12424 WILSHIRE BOULEVARD STREET 2: SUITE 745 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310-820-8100 MAIL ADDRESS: STREET 1: 12424 WILSHIRE BOULEVARD STREET 2: SUITE 745 CITY: LOS ANGELES STATE: CA ZIP: 90025 D/A 1 primary_doc.xml X0707 D/A LIVE 0001530766 BioSig Technologies, Inc. 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 310-820-8100 DELAWARE None None Corporation true 2011 Kenneth Londoner 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Director Jonathan Steinhouse 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Asher Holzer 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Roy Tanaka 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Seth Fischer 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Steve Chaussy 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Chief Financial Officer Patrick Gallagher 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Gregory Cash 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Director President and Chief Executive Officer Jeffrey O'Donnell 12424 WILSHIRE BOULEVARD SUITE 745 Los Angeles CA CALIFORNIA 90025 Director Biotechnology Decline to Disclose 06b true 0001530766-15-000003 2014-12-19 false true true false 0 Laidlaw & Company (UK) Ltd. 119037 None None 546 5th Avenue, 5th Floor New York NY NEW YORK 10036 AR ARKANSAS CA CALIFORNIA CT CONNECTICUT DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KS KANSAS LA LOUISIANA ME MAINE MA MASSACHUSETTS MI MICHIGAN NE NEBRASKA NJ NEW JERSEY NC NORTH CAROLINA OH OHIO OK OKLAHOMA PA PENNSYLVANIA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS VA VIRGINIA WV WEST VIRGINIA true 10000000 4009000 5991000 This represents consideration of $339,500, $172,600,$1,071,000, $842,500, $557,500 and $1,025,900 for the Issuer's first, second, third, fourth, fifth and sixth closing, occurring on 12/19/14,12/30/14, 1/27/15, 2/10/15, 2/27/15 and 3/31/15 respectively. false 107 481080 0 The Issuer also issued five-year warrants to purchase a total of 400,900 shares of common stock at an exercise price of $3.75 per share to the placement agent as consideration for serving as the placement agent. 0 false BioSig Technologies, Inc. Gregory Cash Gregory Cash President and Chief Executive Officer 2015-04-03